文獻(xiàn)引用
欣博盛生物科技有限公司（NeoBioscience Technology Co, Ltd）是一家致力于生命科學(xué)和生物技術(shù)領(lǐng)域的高科技企業(yè)，公司由在國(guó)內(nèi)科研試劑領(lǐng)域有著十幾年從業(yè)經(jīng)驗(yàn)的專業(yè)技術(shù)團(tuán)隊(duì)和企業(yè)管理團(tuán)隊(duì)組建而成，公司自主研發(fā)的ELISA試劑盒品質(zhì)卓越，行業(yè)領(lǐng)先，在國(guó)內(nèi)眾多重點(diǎn)實(shí)驗(yàn)室得到廣泛使用，深受廣大科研工作者的好評(píng)。
欣博盛品牌ELISA自推出以來廣受權(quán)威認(rèn)可，得到多篇SCI文獻(xiàn)引用，其中包括Nature，Nature Immunology，PANS，Cell Research等頂刊文獻(xiàn)引用；同時(shí)有數(shù)千篇國(guó)內(nèi)核心期刊、博士及碩士論文引用。
欣博盛生物共有3214篇SCI文獻(xiàn)引用。您可以通過篩選功能查看感興趣的文獻(xiàn)。
| 文獻(xiàn) | 指標(biāo) | 種屬 | 樣本類型 |
|---|---|---|---|
| Yao Z, S. X., Cao S, et al. . Role of the Exogenous HCV Core Protein in the Interaction of Human Hepatocyte Proliferation and Macrophage Sub-Populations. PLoS ONE 29 September 2014 (2014). Link | TGF-β1 | Human | 常規(guī)樣本 |
| Y Yang, M. X., X Zhang, et al. Decreased IL-35 levels in patients with immune thrombocytopenia. Human Immunology August 2014 (2014). Link | TGF-β1 IL-10 | Human | 常規(guī)樣本 |
| Cheng G, J. Q., Nie S, et al. Dynamic changes in CD4 (+) CD25 (+) regulatory T cell activity in patients with acute decompensated heart failure. Int J Clin Exp Med August 2017 (2017). Link | TGF-β1 IL-10 | Human | 常規(guī)樣本 |
| Ran J, W. J., Dai Z, et al. Irradiation-Induced Changes in the Immunogenicity of Lung Cancer Cell Lines: Based on Comparison of X-rays and Carbon Ions. Frontiers in Public Health 22 April 2021 (2021). Link | TGF-β1 IL-10 | Human | 常規(guī)樣本 |
| Zhang Q, X. W., Xue B Z, et al. Growth factors contribute to the mediation of angiogenic capacity of glioma?associated mesenchymal stem cells. Oncology Letters 19 January 2021 (2021). Link | TGF-β1 PDGF-BB | Human | 常規(guī)樣本 |
| Chen H, W. Z., Yang N, et al. Decorin inhibits proliferation and metastasis in human bladder cancer cells by upregulating P21. Medicine 1 July 2022 (2022). Link | TGF-β1 | Human | 常規(guī)樣本 |
| Chen X, L. R., Zhao H, et al. Phenotype transition of fibroblasts incorporated into patient-derived oral carcinoma organoids. Oral Diseases 5 November 2021 (2021). Link | TGF-β1 | Human | 常規(guī)樣本 |
| Da X, L. Z., Huang X, et al. AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin α7-mediated inhibition of TGF-β1 maturation and ERK1/2 signaling. Nature Communications 20 April 2023 (2023). Link | TGF-β1 | Human | 常規(guī)樣本 |
| Tian H, W. G., Sang W, et al. Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy. Nano Today 25 January 2022 (2022). Link | TGF-β1 | Human | 常規(guī)樣本 |
| Wang Z, L. Q., Risu N, et al. Galunisertib enhances chimeric antigen receptor-modified T cell function. European Journal of Histochemistry 19 June 2020 (2020). Link | TGF-β1 | Human | 常規(guī)樣本 |
